Will Johnson & Johnson (JNJ) Q3 Innovative Medicine revenue be above __?
7.0 pts (24h)WeeklyBusiness & Corporate1d
PolymarketCheck availabilityNo KYCVerified resolution dataWell calibratedSelected book midpoint
$16.6B · —
Loading selected book…
Book received (not venue quote time): —
Stored reference
$16.6B 65%Leader of 5 outcomes
$16.6B 65%Market quality
37 / 100
Low quality24h Volume
$3.7K
Liquidity
$1.4K
Low liquidityBid / Ask
— / —
$16.6BSpread
—
Comments
0
Market data
Updated 11 minutes ago
Oct 9, 26, 1:43 PM UTCOct 13, 26, 1:30 PM UTC
Chart and changes show stored historical probabilities, not the selected live book.
Trends
Selected row: book midpoint. Other rows: stored references, possibly normalized; 24h changes use stored history.
Venue terms
Source: Polymarket
Informational venue terms only; CoinRithm paper trading uses its own rules.
- Minimum order (shares):
- 5
- Tick size:
- 1 percentage points
- Fees:
- Yes
Market depth · $16.6B
Loading selected book…
Book received (not venue quote time): —
Related Markets
Related questions for context, not a comparison of equivalent contracts.
Will Johnson & Johnson (JNJ) Q3 MedTech revenue be above __?
PolymarketWill Johnson & Johnson (JNJ) beat quarterly earnings?
PolymarketWill Johnson & Johnson (JNJ) beat quarterly earnings?
LimitlessWhat will Johnson & Johnson say during their next earnings call?
KalshiWill Joaquin Duato (CEO of Johnson & Johnson) be charged with a serious crime before 2030?
Manifold MarketsElon Musk # tweets October 6 - October 13, 2026?
PolymarketRules
This market will resolve to "Yes" if Johnson & Johnson's Innovative Medicine revenue for the upcoming third fiscal quarter, as reported in its official company earnings materials, is above the listed amount.
- Otherwise, this market will resolve to "No".
- The specified metric will be considered as reported in the company's official earnings materials.
- Subsequent revisions will not be considered.
- If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to "No".
- If the specified company does not release quarterly earnings materials for the specified quarter by November 30, 2026, 11:59 PM ET, this market will resolve to "No".